We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Letter to the Editor: SFlt-1 and PlGF Levels in Pregnancies Complicated by SARS-CoV-2 Infection.
- Authors
Giardini, Valentina; Ornaghi, Sara; Acampora, Eleonora; Vasarri, Maria Viola; Arienti, Francesca; Gambacorti-Passerini, Carlo; Casati, Marco; Carrer, Andrea; Vergani, Patrizia
- Abstract
Subsequently, other authors confirmed the increased sFlt-1 values in severe COVID-19 and identified sFlt-1 as a biomarker to predict survival and thrombotic accidents in COVID-19 patients [[9]]. Keywords: COVID-19; SARS-CoV-2; angiogenic factors; sFlt-1; endothelial dysfunction EN COVID-19 SARS-CoV-2 angiogenic factors sFlt-1 endothelial dysfunction 2377 2377 1 12/30/21 20211201 NES 211201 Dear Editor We read with interest the work by Espino-y-Sosa and colleagues [[1]], who recently reported that the Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) ratio could be a good predictor of adverse outcomes, including pneumonia, intensive care unit (ICU) admission, intubation, viral sepsis, and death, among pregnant women with COVID-19. PlGF values were not significantly affected by COVID-19, but the sFlt1/PlGF ratio was substantially higher in COVID-19-positive compared with COVID-19-negative pneumonia.
- Subjects
SARS-CoV-2; PREECLAMPSIA; FETAL growth disorders; SMALL for gestational age; INFECTION
- Publication
Viruses (1999-4915), 2021, Vol 13, Issue 12, p2377
- ISSN
1999-4915
- Publication type
Article
- DOI
10.3390/v13122377